First Databank (FDB) is a major provider of drug and medical device databases that help inform healthcare professionals to make decisions.

FDB has its headquarters in San Francisco, California, and has other offices in Indianapolis, Indiana, Exeter, England, Dubai, UAE and Hyderabad, India.

[3] Beginning in 2020, FDB partnered with Amazon and its Alexa devices to provide drug information and answer medication questions.

[4] During the COVID-19 pandemic, FDB posted drug data (regarding remdesivir, chloroquine, and hydroxychloroquine) and medical device-related coronavirus information to its website.

The technology displays accurate, real-time data at the point of prescribing, allowing physicians to find affordable alternatives for medications specific to a patient's health needs and insurance benefits.

FDB will offer RxRevu's prescription cost and coverage solution to current and future hospital, health system, and EHR clients.

The database is expected to affect the number of adverse drug reactions and side effects at facilities that have adopted the electronic order entry systems.

The CDS derived from this solution provides specificity for clinical decisions and is linked to the related generic medication alerts which can be filtered out/customized using FDB AlertSpace.

The settlement required First DataBank (FDB) to reduce the AWP mark-up from 1.25 to 1.20 times the Wholesale Acquisition Cost (WAC) for 1,442 NDCs identified in the litigation.